219 related articles for article (PubMed ID: 22644841)
1. Cerebrospinal fluid BAFF and APRIL levels in neuromyelitis optica and multiple sclerosis patients during relapse.
Wang H; Wang K; Zhong X; Qiu W; Dai Y; Wu A; Hu X
J Clin Immunol; 2012 Oct; 32(5):1007-11. PubMed ID: 22644841
[TBL] [Abstract][Full Text] [Related]
2. [Investigation of B-cell activating factor in serum and cerebrospinal fluid of patients with neuromyelitis optical].
Yang F; Huang D; Wu W
Nan Fang Yi Ke Da Xue Xue Bao; 2015 Mar; 35(3):380-3. PubMed ID: 25818784
[TBL] [Abstract][Full Text] [Related]
3. Preferential increase of B-cell activating factor in the cerebrospinal fluid of neuromyelitis optica in a white population.
Vaknin-Dembinsky A; Brill L; Orpaz N; Abramsky O; Karussis D
Mult Scler; 2010 Dec; 16(12):1453-7. PubMed ID: 20935029
[TBL] [Abstract][Full Text] [Related]
4. Elevated C-X-C motif ligand 13 and B-cell-activating factor levels in neuromyelitis optica during remission.
Wang S; Yang T; Wan J; Zhang Y; Fan Y
Brain Behav; 2017 Apr; 7(4):e00648. PubMed ID: 28413701
[TBL] [Abstract][Full Text] [Related]
5. Urinary trypsin inhibitor levels are reduced in cerebrospinal fluid of multiple sclerosis and neuromyelitis optica patients during relapse.
Shu Y; Li R; Yang Y; Dai Y; Qiu W; Chen Y; Zhao Z; Lu Z; Hu X
Neurochem Int; 2015 Feb; 81():28-31. PubMed ID: 25555815
[TBL] [Abstract][Full Text] [Related]
6. Cerebrospinal fluid levels of BAFF and APRIL in untreated multiple sclerosis.
Piazza F; DiFrancesco JC; Fusco ML; Corti D; Pirovano L; Frigeni B; Mattavelli L; Andreoni S; Frigo M; Ferrarese C; Tredici G; Cavaletti G
J Neuroimmunol; 2010 Mar; 220(1-2):104-7. PubMed ID: 20149932
[TBL] [Abstract][Full Text] [Related]
7. Impaired regulatory function and enhanced intrathecal activation of B cells in neuromyelitis optica: distinct from multiple sclerosis.
Quan C; Yu H; Qiao J; Xiao B; Zhao G; Wu Z; Li Z; Lu C
Mult Scler; 2013 Mar; 19(3):289-98. PubMed ID: 22864301
[TBL] [Abstract][Full Text] [Related]
8. Cerebrospinal fluid biomarkers implicated in the pathogenesis of anti-neutrophil cytoplasmic antibody-related hypertrophic pachymeningitis.
Ikeda J; Shimojima Y; Usami Y; Ueno KI; Kishida D; Sekijima Y
Clin Rheumatol; 2020 Jun; 39(6):1803-1811. PubMed ID: 32036585
[TBL] [Abstract][Full Text] [Related]
9. Cerebrospinal fluid levels of a proliferation-inducing ligand (APRIL) are increased in patients with neuropsychiatric systemic lupus erythematosus.
Hopia L; Thangarajh M; Khademi M; Laveskog A; Wallström E; Svenungsson E; Andersson M
Scand J Rheumatol; 2011; 40(5):363-72. PubMed ID: 21585290
[TBL] [Abstract][Full Text] [Related]
10. Cerebrospinal fluid IL-21 levels in Neuromyelitis Optica and multiple sclerosis.
Wu A; Zhong X; Wang H; Xu W; Cheng C; Dai Y; Bao J; Qiu W; Lu Z; Hu X
Can J Neurol Sci; 2012 Nov; 39(6):813-20. PubMed ID: 23041403
[TBL] [Abstract][Full Text] [Related]
11. Raised intrathecal levels of APRIL and BAFF in patients with systemic lupus erythematosus: relationship to neuropsychiatric symptoms.
George-Chandy A; Trysberg E; Eriksson K
Arthritis Res Ther; 2008; 10(4):R97. PubMed ID: 18718031
[TBL] [Abstract][Full Text] [Related]
12. Raised cerebrospinal fluid BAFF and APRIL levels in anti-N-methyl-d-aspartate receptor encephalitis: Correlation with clinical outcome.
Deng B; Liu XN; Li X; Zhang X; Quan C; Chen XJ
J Neuroimmunol; 2017 Apr; 305():84-91. PubMed ID: 28284352
[TBL] [Abstract][Full Text] [Related]
13. Cerebrospinal fluid levels of CXCL13 are elevated in neuromyelitis optica.
Zhong X; Wang H; Dai Y; Wu A; Bao J; Xu W; Cheng C; Lu Z; Qiu W; Hu X
J Neuroimmunol; 2011 Dec; 240-241():104-8. PubMed ID: 22036953
[TBL] [Abstract][Full Text] [Related]
14. BAFF/APRIL system in pediatric OMS: relation to severity, neuroinflammation, and immunotherapy.
Pranzatelli MR; Tate ED; McGee NR; Travelstead AL; Colliver JA; Ness JM; Ransohoff RM
J Neuroinflammation; 2013 Jan; 10():10. PubMed ID: 23324534
[TBL] [Abstract][Full Text] [Related]
15. Cerebrospinal fluid high-mobility group box protein 1 in neuromyelitis optica and multiple sclerosis.
Wang H; Wang K; Wang C; Xu F; Zhong X; Qiu W; Hu X
Neuroimmunomodulation; 2013; 20(2):113-8. PubMed ID: 23328212
[TBL] [Abstract][Full Text] [Related]
16. Analyses of haptoglobin level in the cerebrospinal fluid and serum of patients with neuromyelitis optica and multiple sclerosis.
Chang KH; Tseng MY; Ro LS; Lyu RK; Tai YH; Chang HS; Wu YR; Huang CC; Hsu WC; Kuo HC; Chu CC; Chen CM
Clin Chim Acta; 2013 Feb; 417():26-30. PubMed ID: 23262373
[TBL] [Abstract][Full Text] [Related]
17. Notable increased cerebrospinal fluid levels of soluble interleukin-6 receptors in neuromyelitis optica.
Wang H; Wang K; Zhong X; Dai Y; Qiu W; Wu A; Hu X
Neuroimmunomodulation; 2012; 19(5):304-8. PubMed ID: 22777162
[TBL] [Abstract][Full Text] [Related]
18. Increased levels of CSF CD59 in neuromyelitis optica and multiple sclerosis.
Uzawa A; Mori M; Uchida T; Masuda H; Ohtani R; Kuwabara S
Clin Chim Acta; 2016 Jan; 453():131-3. PubMed ID: 26686775
[TBL] [Abstract][Full Text] [Related]
19. Cerebrospinal fluid light and heavy neurofilaments in neuromyelitis optica.
Wang H; Wang C; Qiu W; Lu Z; Hu X; Wang K
Neurochem Int; 2013 Dec; 63(8):805-8. PubMed ID: 24161620
[TBL] [Abstract][Full Text] [Related]
20. Cerebrospinal fluid α-synuclein levels are elevated in multiple sclerosis and neuromyelitis optica patients during replase.
Wang H; Wang K; Xu W; Wang C; Qiu W; Zhong X; Dai Y; Wu A; Hu X
J Neurochem; 2012 Jul; 122(1):19-23. PubMed ID: 22469018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
